Chang, Y.-K.; Tseng, H.-H.; Leung, C.-M.; Lu, K.-C.; Tsai, K.-W.
Targeted Next-Generation Sequencing-Based Multiple Gene Mutation Profiling of Patients with Rectal Adenocarcinoma Receiving or Not Receiving Neoadjuvant Chemoradiotherapy. Int. J. Mol. Sci. 2022, 23, 10353.
https://doi.org/10.3390/ijms231810353
AMA Style
Chang Y-K, Tseng H-H, Leung C-M, Lu K-C, Tsai K-W.
Targeted Next-Generation Sequencing-Based Multiple Gene Mutation Profiling of Patients with Rectal Adenocarcinoma Receiving or Not Receiving Neoadjuvant Chemoradiotherapy. International Journal of Molecular Sciences. 2022; 23(18):10353.
https://doi.org/10.3390/ijms231810353
Chicago/Turabian Style
Chang, You-Kang, Hui-Hwa Tseng, Chung-Man Leung, Kuo-Cheng Lu, and Kuo-Wang Tsai.
2022. "Targeted Next-Generation Sequencing-Based Multiple Gene Mutation Profiling of Patients with Rectal Adenocarcinoma Receiving or Not Receiving Neoadjuvant Chemoradiotherapy" International Journal of Molecular Sciences 23, no. 18: 10353.
https://doi.org/10.3390/ijms231810353
APA Style
Chang, Y.-K., Tseng, H.-H., Leung, C.-M., Lu, K.-C., & Tsai, K.-W.
(2022). Targeted Next-Generation Sequencing-Based Multiple Gene Mutation Profiling of Patients with Rectal Adenocarcinoma Receiving or Not Receiving Neoadjuvant Chemoradiotherapy. International Journal of Molecular Sciences, 23(18), 10353.
https://doi.org/10.3390/ijms231810353